DHA ORIGEN NPD1
Commercial- Indications
- Eye health, Neurodegeneration
Company intelligence / Profile preview
Nutilab
Pietermaritzburg, Kwa-Zulu Natal, South Africanutilab-dha.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
No clinical results available. Companies operate in healthcare PR/AI analytics (mental health), pharmaceutical manufacturing/distribution, or nutraceutical contract manufacturing rather than traditional biotech drug development pipelines.
- Therapeutic areas
- OtherPsychiatryMetabolic DisordersNeurology
- Modalities
- Small moleculeHerbal formulationsVitamins and mineralsProbiotics
- Industry
- Contract Manufacturing Organization
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
PT. Nutrilab Pratama is a distributor partner of iNtRON Biotechnology in Indonesia
Beyond the preview
Go deeper on Nutilab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nutilab.